Anika Therapeutics
ANIK
138 hedge funds and large institutions have $398M invested in Anika Therapeutics in 2015 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 52 increasing their positions, 46 reducing their positions, and 15 closing their positions.
13% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 15
13% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 46
1% more funds holding
Funds holding: 136 → 138 (+2)
1% more call options, than puts
Call options by funds: $2.33M | Put options by funds: $2.31M
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1% less capital invested
Capital invested by funds: $401M → $398M (-$3.54M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$15.2M |
| 2 |
Kayne Anderson Rudnick Investment Management
Los Angeles,
California
|
+$11.9M |
| 3 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
+$5.04M |
| 4 |
Millennium Management
New York
|
+$3.9M |
| 5 |
BA
Boston Advisors
Boston,
Massachusetts
|
+$3.19M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LCP
Lombardia Capital Partners
Pasadena,
California
|
-$7.12M |
| 2 |
GAM
Gotham Asset Management
New York
|
-$5.9M |
| 3 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$4.34M |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$4.06M |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$3.57M |
ANIK Hedge Fund Activity: Q3 2015 in Review
138 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Anika Therapeutics (ANIK) for Q3 2015, worth a combined $398M — down 0.88% from $401M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new ANIK positions and 15 closed out — a net gain of 2 holders — while 52 added to existing stakes and 46 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $15.2M. The largest seller was Lombardia Capital Partners, cutting an estimated $7.12M.
- 138 institutional investors held Anika Therapeutics (ANIK) as of Q3 2015, up from 136 in Q2 2015.
- Funds reported $398M of Anika Therapeutics stock for Q3 2015, down 0.88% quarter-over-quarter.
- 17 funds opened new Anika Therapeutics positions in Q3 2015 and 15 closed out, a net change of +2 holders.
- The largest Anika Therapeutics buyer in Q3 2015 was Wellington Management Group, an estimated $15.2M added.
- The largest Anika Therapeutics seller in Q3 2015 was Lombardia Capital Partners, an estimated $7.12M sold.
Based on aggregated 13F filings for Q3 2015.